Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

New contraceptive wins thumbs up

Posted 30 November 2021 AM

Adelaide-based Mayne Pharma has gained approval from the TGA for its novel oral contraceptive Nextstellis, marking the first new contraceptive hormone in Australia in a decade.

Nextstellis is the first and only pill containing estetrol (E4), an estrogen produced by the human body during pregnancy, now derived from a plant source, and combined with drospirenone (DRSP).

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.